News | October 05, 2008

Syracuse Radiation Oncology Adopts RapidArc

October 6, 2008 - Doctors in Syracuse, NY, have deployed RapidArc radiotherapy technology from Varian Medical Systems.

A new weapon in the fight against cancer, RapidArc delivers a precise image-guided IMRT treatment in two minutes or less, which is two to eight times faster than was previously possible with conventional IMRT, said Varian.

A 70-year-old prostate cancer patient was the first person to begin a course of RapidArc treatments at Syracuse Radiation Oncology, an early adopter and the one of the first sites in upstate New York to offer this form of treatment. Each of his daily treatments is taking just under two minutes to deliver.

“Compared with a traditional IMRT approach, we’re finding that a RapidArc treatment is noticeably faster to deliver,” said Neil Mariados, M.D., radiation oncologist, Syracuse Radiation Oncology. “A shorter treatment time means that patients spend less time holding still, and we believe this has the potential to improve treatment accuracy as the targeted tumor is less likely to shift position during a shorter treatment. Because RapidArc provides the accuracy we demand in a patient's radiotherapy, but in a shorter time frame, we are able to provide exceptional care to each of them.”

For more information: www.varian.com

Related Content

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...
non-small cell lung cancer, NSCLC, IMRT, toxicity, intensity modulated radiation therapy, 3-D CRT, ASTRO 2015
News | Lung Cancer | October 28, 2015
October 28, 2015 — An analysis of an international, cooperative-led trial of patients with locally advanced non-small
pediatric ependymoma patients, immediate post-surgical radiation therapy, Children's Oncology Group ACNS0121 trial, ASTRO 2015
News | Radiation Therapy | October 22, 2015
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative...
post-prostatectomy IG-IMRT, image-guided intensity-modulated radiation therapy, toxicity, ASTRO, Practical Radiation Oncology
Feature | Intensity Modulated Radiation Therapy (IMRT) | October 06, 2015
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in...
IMRT, chemo-radiation, oropharyngeal, head and neck cancer, combination, quality of life, study, University of Michigan
News | Intensity Modulated Radiation Therapy (IMRT) | August 14, 2015
Combining intensity-modulated radiotherapy (IMRT) with chemotherapy to treat locally advanced oropharyngeal (head and...
Overlay Init